We’re Bearish, but we’re up 243% in Provention Bio (PRVB) Today.
And up 416%, from Adding it to 2022 Watch List!
Great way to wake up after a night of hard partying at the C-3.
How pray...
Interview: Rokas Sidlauskas, Marketing Director of Society Pass (SOPA)
Shares Roadmap to Expand the Society Pass (SoPa Group) Ecosystem in South East Asia.
Related News
SoPa Vietnam CEO: "Buying Handycart Vietnam, Sopa ecosystem will have...
Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.
Stormin..Live Quote
We're still not sure how to pronounce it...but Wall Street likes it.
News Archive
Unicycive Therapeutics (UNCY) $2.73. We're now up 249%.
Unicycive (UNCY) Shoots and...
Meet Dennis Nguyen CEO of Start-Up Investor, the Society Pass (Symbol: SOPA)
See a Dazzling Presentation!
Society Pass (SOPA) has quickly acquired 8 companies since going public in late 2021, after a $26 million IPO on...
New Player in the Electric Vehicle (EV) Market?
Principal Solar (PSWW) Highlights one of it's Portfolio Holdings, eTruck Transportation.
Alternative Energy Stock Review
The exciting thing about Principal Solar (PSWW), a tiny energy and...
Freedom Holding (FRHC) Acquires LD Micro From SRAX, Inc
Purchase brings pre-eminent small-cap platform to the Freedom family
Freedom U.S. Markets, LLC, a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ: FRHC), announced today that it...
Unicycive (UNCY) Shoots and Scores, up 40% Today!
We're up 126% Since December, and That Ain't Bad.
Note: This isn't the end, it's just the beginning.
LIVE QUOTE
Adding Unicycive (UNCY) $0.75 to...
EyeOnChannel.com
Eye on Channel is a digital video giant that connects millions of viewers to targeted and preferred demographics in destinations including Boston, California, Chicago,...
The Silent Killer: The Impact Of Kidney Disease On Patients And Their Caregivers. Unicyive...
Los Altos, CA --News Direct-- Unicycive Therapeutics, Inc.
By Julian Richard, Benzinga
Unicycive Therapeutics Inc (NASDAQ: UNCY) is a biopharmaceutical company committed to developing effective and safe...
Booya. We’re up 143% With Ardelyx (ARDX) in Three Months – and That Ain’t...
Ardelyx Adds 16% to $3.82 as Wedbush Upgrades After Q4 Earnings.
Ardelyx ( NASDAQ: ARDX ) gained 35% Friday after the biotech reported better-than-expected financials...